Systematic review and meta-analysis of risk prediction models for anti-tuberculosis drug-induced liver injury in East Asian populations. [PDF]
Li H, Feng X, Zheng X, Zhong X.
europepmc +1 more source
Feasibility of tuberculosis drug-induced liver injury screening under programme settings in Southern India. [PDF]
Natarajan M +13 more
europepmc +1 more source
Precision treatment and frontier advances of glycyrrhizin preparations in drug-induced liver injury (DILI). [PDF]
Qiu D +15 more
europepmc +1 more source
Hepatic expression of IL-8, IL-10, and CXCL-14 in drug-induced liver injury: correlation with histopathology and prognostic value. [PDF]
Hao D +5 more
europepmc +1 more source
Evolution of artificial intelligence and machine learning in DILI toxicogenomics: from descriptive profiling to mechanistic insights. [PDF]
Rahman MS, Chen M.
europepmc +1 more source
Metabolomics and Machine Learning Uncover 5'-Methylthioadenosine as a Metabolic Indicator of Mixed-Pattern Drug-Induced Liver Injury. [PDF]
Zhang J +7 more
europepmc +1 more source
A serum Golgi Protein 73 (GP73)-based model for evaluating inflammation associated with drug-induced liver injury. [PDF]
Wei Y +8 more
europepmc +1 more source
Rapid-Onset Amoxicillin-Clavulanate Liver Injury Requires Stronger Exclusion of Alternative Causes and Fuller Causality Reporting in Atypical DILI Case Reports. [PDF]
Awan MA, Raza HU.
europepmc +1 more source
Shifting Public Interest in Liver Health, Hepatotoxic Medications, and Dietary Supplements in Kazakhstan: A Five-Year Google Trends Infodemiology Study. [PDF]
Saparbay J, Burkitbayev Z.
europepmc +1 more source
Common Causes of Drug-Induced Liver Injury in 2025. [PDF]
Björnsson ES.
europepmc +1 more source

